The Lancet Gastroenterology & Hepatology in conversation with
A podcast by The Lancet Group
88 Episoade
-
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Publicat: 09.09.2021 -
Raymond Henderson on the economic burden of colorectal cancer
Publicat: 12.08.2021 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Publicat: 22.06.2021 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Publicat: 03.06.2021 -
Matthew Akiyama on hepatitis C in prisons
Publicat: 12.04.2021 -
Monika Sarkar on reproductive health in women with liver disease
Publicat: 11.03.2021 -
Colorectal cancer risk in patients with Crohn’s disease
Publicat: 12.03.2020 -
Liver damage in young adults
Publicat: 17.01.2020 -
Treatments for IBS
Publicat: 14.01.2020 -
Statins and decompensated cirrhosis
Publicat: 27.11.2019 -
Global burden of pancreatic cancer and colorectal cancer
Publicat: 04.11.2019 -
Paediatric inflammatory bowel disease
Publicat: 12.09.2019 -
Transplanting hepatitis C-infected hearts
Publicat: 28.08.2019 -
Primary anastomosis as a treatment for diverticulitis
Publicat: 31.07.2019 -
Faecal microbiota transplantation in IBS
Publicat: 30.07.2019 -
Treating faecal incontinence in women
Publicat: 17.07.2019 -
Viral hepatitis in children & adolescents
Publicat: 23.05.2019 -
Whole-body MRI: the STREAMLINE trials
Publicat: 11.05.2019 -
A new drug for short bowel syndrome
Publicat: 05.04.2019 -
Eosinophilic oesophagitis endotype classification
Publicat: 09.03.2019
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
